The Use of Phase 2 Interim Analysis to Expedite Drug Development Decisions
Anny-Yue YIN, Senior Statistical Scientist, Biometrics, Roche (China)
殷悦 高级统计专家, 罗氏药品临床开发亚太中心
Variable Selection for Optimal Treatment Regimens with Survival Data
Yuan GENG, Senior Biostatistician, Biometrics and Data Management, Pan Asia/META, Boehringer Ingelheim China
耿原 高级统计师, 勃林格殷格翰中国 生物统计 泛亚/中东、土耳其和非洲地区
A Bayesian Adaptive Dose Finding Method for Phase I Oncology Trials
Jin XU, Professor, Department of Statistics and Actuarial Science, East China Normal University
徐进 教授, 华东师大统计与精算学系